CNAG develops new tool to help detect allele-specific methylation

The innovative bioinformatics tool 'asms' analyzes thousands of genomic loci without requiring prior genetic information.

Generic image of glowing methylation patterns on a DNA double helix, abstract representation of bioinformatics analysis.
AI

Generic image of glowing methylation patterns on a DNA double helix, abstract representation of bioinformatics analysis.

Researchers at CNAG have developed asms, a new bioinformatics tool that simplifies the detection of allele-specific methylation (ASM) across thousands of genomic regions, without needing prior genetic information.

The National Centre for Genomic Regulation (CNAG) has unveiled asms, a novel bioinformatics tool designed to analyze thousands of genomic loci by grouping long-read sequencing data based on their methylation patterns. This innovation enables researchers to pinpoint promising genomic regions for further study, contributing to a deeper understanding of human biology and paving the way for the identification of epigenetic variants involved in disease.
Published in NAR Genomics and Bioinformatics, the tool was developed by researchers from CNAG's Functional Genomics Team and Bioinformatics Development and Statistical Genomics Team. It overcomes the limitations of previous methods that relied on computationally intensive phasing and genetic variant information, particularly in genomic regions with low genetic variability.
DNA methylation is a chemical mark that controls gene activity or silencing without altering the DNA sequence. Differences in this methylation between the two alleles (copies of a gene inherited from each parent) are known as allele-specific methylation (ASM). These differences, which can arise from mechanisms like genomic imprinting or genetic variants, influence gene expression and play a key role in disease development.
"The genome still contains many regulatory regions that remain largely unexplored," highlights Dr. Anna Esteve Codina, Functional Genomics Team Leader and corresponding author of the study. "asms helps us identify where allele-specific methylation is likely to be occurring, revealing the genomic regions with the greatest potential for discovery. By focusing future research on these regions, we can better understand the mechanisms underlying human disease and uncover new opportunities for diagnosis and treatment."
Emanuele Rainieri, first author of the study and researcher in the Bioinformatics Development and Statistical Genomics Team at CNAG, explains, "Allele-specific methylation reflects an epigenetic difference between the two copies of a genomic region. These differences can arise through several biological mechanisms, including genomic imprinting, X-chromosome inactivation, cis-regulatory genetic variation, and disease-associated epigenetic dysregulation. By systematically identifying these regions, ASMS provides a framework for investigating how allele-specific regulation contributes to normal biology and human disease."
The asms tool, freely available as open-source on GitHub, has been validated using Oxford Nanopore Technologies (ONT) sequencing data and can be applied to data generated by any sequencing platform that stores DNA base modifications in BAM files using MM and ML tags. This innovative method represents a new step towards advancing our understanding of the epigenetic mechanisms underlying human disease, offering valuable targets for further research.
Based on information from the official source: CNAG - Centre Nacional d'Anàlisi Genòmica (18/11/2026)